CoChat

Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases

Stefanich, Eric G., Rae, Julie, Sukumaran, Siddharth, Lutman, Jeff, Lekkerkerker, Annemarie, Ouyang, Wenjun, Wang, Xiaoting, Lee, Donna, Danilenko, Dimitry M., Diehl, Lauri, Loyet, Kelly M., Herman, Ann · 2018 · Biochemical Pharmacology
Cited by 55

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Graphical abstract Figure. No Caption available. ABSTRACT Interleukin (IL)‐22 plays protective roles in infections and in inflammatory diseases that have been linked to its meditation of innate immunity via multiple mechanisms. IL‐22 binds specifically to its heterodimeric receptor, which is expressed on a variety of epithelial tissues. UTTR1147A is a recombinant fusion protein that links the human cytokine IL‐22 with the Fc portion of human immunoglobulin (Ig) G4. Here, we report extensive in vitro and in vivo nonclinical studies that were conducted to characterize the pharmacological activity of UTTR1147A. The in vitro activity and potency of UTTR1147A were analyzed using primary human hepatocytes and human colonic epithelial cell lines. Assessment of in vivo efficacy was performed in a mouse colitis model and by measuring relevant pharmacodynamic biomarkers, including antimicrobial peptides REG3A/&bgr;, serum amyloid protein A (SAA) and lipopolysaccharide binding protein (LBP). The pharmacokinetic and pharmacodynamic characteristics of UTTR1147A were assessed in healthy mice, rats and cynomolgus monkeys. UTTR1147A induced STAT3 activation through binding to IL‐22 receptor expressed in primary human hepatocytes and human colon cell lines. In both, activation occurred in a concentration‐dependent manner with similar potencies. In the mouse colitis model, murine IL‐22Fc‐ (muIL‐22Fc) treated groups at doses of 1.25 &mgr;g and above had statistically lower average histologic colitis scores compared to the control treated group. Administration of muIL‐22Fc or UTTR1147A was associated with a dose‐dependent induction of PD markers REG3&bgr; and SAA in rodents as well as REG3A, SAA and LBP in cynomolgus monkeys. The combined data confirm pharmacological activity of IL‐22Fc and support potential regenerative and protective mechanisms in epithelial tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bcp.2018.03.031

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 55

Metadata

Authors
Stefanich, E. G., Rae, J., Sukumaran, S., Lutman, J., Lekkerkerker, A., Ouyang, W., Wang, X., Lee, D., Danilenko, D. M., Diehl, L., Loyet, K. M., & Herman, A.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2018-06
Volume
152
Pages
224-235
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2794649635
Cited by
55
References
3
FWCI
1.77
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases. https://app.cochat.ai/papers/10.1016/j.bcp.2018.03.031
The paper
Stefanich, E. G., Rae, J., Sukumaran, S., Lutman, J., Lekkerkerker, A., Ouyang, W., Wang, X., Lee, D., Danilenko, D. M., Diehl, L., Loyet, K. M., & Herman, A. (2018). Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2018.03.031

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.